OKLAHOMA CITY, Sept. 14 /PRNewswire-FirstCall/ -- PD-Rx Pharmaceuticals, Inc. , a publicly held corporation, today announced that it has completed the infrastructure of an on-line web based pharmaceutical tracking system called "Pedigree Security Network" to combat the use of counterfeit drugs and provide each customer with the ability to authenticate the medications that they purchase from PD-Rx Pharmaceuticals.
PD-Rx is one of the first pharmaceutical firms to offer such a tracking system. The PD-Rx website will provide each customer with the ability to interface with our data files on every medication, providing them with the security and comfort of knowing the true pedigree of all medications sourced through PD-Rx Pharmaceuticals.
Mr. Shawn Stephens, IMS Director stated, "Our Web based Pedigree System is completely integrated with our internal accounting systems. From the point of our order, thru any packaging that may occur, to the point of shipment to the customer. The Security Network actually builds the pedigree from our accounting tracking systems already in place. This means instead of storing a 'pedigree paper' for retrieval at some point, our system builds it in place and display's the data as requested."
With the use of custom designed bar codes, each customer will be able to scan the individual product and print a secure pedigree at anytime on-line with PD-Rx. The pedigree includes additional information such as common carrier tracking numbers, the exact amount of each lot number shipped, past shipments, organoleptic markings and product descriptions as defined by our Quality Control Officers from our production plant. Future plans will allow PD-Rx to first convert to a two-dimensional barcode then to an RFID system that will store additional information and security measures as technology because economically feasible and the balance of the industry is capable of supporting such technology.
ABOUT THE COMPANY
PD-Rx offers pharmaceutical and management strategies to the healthcare industry. Our management strategies focus on new products, solid business partners, and the specialized segment of the pharmaceutical industry. As a licensed FDA manufacturer and packager, PD-Rx offers a full spectrum of medications and specialized services. Our goal is to develop a matrix of cost containment tools and products that we can merge into any healthcare network to enhance patient care and improve managed care organizations bottom line. We provide proprietary products and prepackaged medications that are viewed by patient, insurance payers, and healthcare providers as a progressive and responsive practice.
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward- looking statements involve known and unknown risks and uncertainties or other factors, which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to vary from those forecast or implied in this release. Factors that might cause such a difference include, without limitation, decline in demand for the company's products or services, and the effect of general economic conditions and factors affecting the industry.
PD-Rx Pharmaceuticals, Inc.